Akcije

Archive of Oncology
kako citirati ovaj članak
podeli ovaj članak

Metrika

  • citati u SCIndeksu: 0
  • citati u CrossRef-u:0
  • citati u Google Scholaru:[]
  • posete u poslednjih 30 dana:2
  • preuzimanja u poslednjih 30 dana:1

Sadržaj

članak: 4 od 25  
Back povratak na rezultate
2019, vol. 25, br. 1, str. 1-8
Characteristics of carcinoembryonic antigen-producing colorectal cancers: A population based study
(naslov ne postoji na srpskom)
aOklahoma State University, Center for Health Sciences, Department of Biochemistry and Microbiology, Tulsa, Oklahoma, USA
bUniversity of Oklahoma, Health Sciences Center, Department of Biostatistics and Epidemiology, Oklahoma City, Oklahoma, USA
cCancer Treatment Centers of America, Tulsa, Oklahoma, USA
dCancer Treatment Centers of America, Tulsa, Oklahoma, USA + Oklahoma State University, Center for Health Sciences, Department of Surgery, Tulsa, Oklahoma, USA

e-adresaprag.t@ctca-hope.com
Sažetak
(ne postoji na srpskom)
Objectives: Serum carcinoembryonic antigen is a tumor marker often found to be elevated in colorectal cancer patients. Elevated carcinoembryonic antigen has been strongly associated with poor prognosis. However, little is known about the patient and tumor characteristics between carcinoembryonic antigen-secreting and non-secreting tumors. Methods: We performed a retrospective analysis of all patients (N=164,187) in the Surveillance, Epidemiology and End Results database diagnosed with colorectal adenocarcinoma from 2010 to 2014. All patients were designated as having either positive/elevated (C1) or negative/normal (C0) pretreatment serum carcinoembryonic antigen level. Results: Of the 164,187 patients, 68,833 (57.0%) had available carcinoembryonic antigen information, and 33,412 (48.5%) had positive/elevated (C1) antigen levels. Median age was 65 years, and 36,464 (53.0%) were male. Patients with C1 cancers were more likely to be female (Odds ratio 1.06), black (Odds ratio 1.62), separated or never married (Odds ratios 1.50 and 1.49, respectively), higher grade (Odds ratios 1.35, 1.64, and 1.72 of moderately, poorly, and undifferentiated cancers, respectively), and of signet ring cell histology (Odds ratio 1.47) compared to males, whites, married participants, well differentiated grade, and adenocarcinoma histology respectively (P<0.001). Multivariate analysis showed that non-Caucasian race, female gender, unmarried status, distal to sigmoid colon location, increasing tumor invasion beyond muscular layer, increasing nodal involvement, and presence of metastases were independent factors associated with the C1 diagnosis. Conclusions: About half of all colorectal adenocarcinomas are associated with elevated pre-treatment serum carcinoembryonic antigen levels. Our study is the first nationwide population-based study quantifying the prevalence of serum carcinoembryonic antigen elevation in the colorectal cancer population, and identifying patient and tumor characteristics associated with elevated carcinoembryonic antigen.
Reference
*** (2012) SAS System for Windows OS. Cary, North Carolina, United States of America: SAS Institute Inc, Version 9.4
*** (2017) SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases - Linked To County Attributes - Total U.S., 1969-2015 Counties. Bethesda, MD: National Cancer Institute, 1973-2014. Updated April 2017
Amri, R., Bordeianou, L.G., Sylla, P., Berger, D.L. (2013) Preoperative carcinoembryonic antigen as an outcome predictor in colon cancer. Journal of Surgical Oncology, 108(1): 14-18
Becerra, A.Z., Probst, C.P., Tejani, M.A., Aquina, C.T., González, M.G., Hensley, B.J., Noyes, K., Monson, J.R., Fleming, F.J. (2016) Evaluating the Prognostic Role of Elevated Preoperative Carcinoembryonic Antigen Levels in Colon Cancer Patients: Results from the National Cancer Database. Annals of Surgical Oncology, 23(5): 1554-1561
Chen, C., Yang, S., Lin, J., Lin, T., Chen, W., Jiang, J., Wang, H., Chang, S. (2005) Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?. Journal of Surgical Research, 124(2): 169-174
Chu, D.Z. J., Erickson, C.A., Russell, M.P., i dr. (1991) Prognostic Significance of Carcinoembryonic Antigen in Colorectal Carcinoma. Archives of Surgery, 126(3): 314
Compton, C., Fenoglio-Preiser, C.M., Pettigrew, N., Fielding, L. P. (2000) American Joint Committee on Cancer Prognostic Factors Consensus Conference: Colorectal Working Group. Cancer, 88(7): 1739-1757
Duffy, M.J., Lamerz, R., Haglund, C., Nicolini, A., Kalousová, M., Holubec, L., Sturgeon, C. (2013) Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines update. International Journal of Cancer, 134(11): 2513-2522
Edge, S.B., Byrd, D.R., Compton, C., i dr. (2010) AJCC Cancer Staging Handbook. New York: Springer, 7th ed
Gabriel, E., Attwood, K., Al-Sukhni, E., Erwin, D., Boland, P., Nurkin, S. (2018) Age-related rates of colorectal cancer and the factors associated with overall survival. Journal of Gastrointestinal Oncology, 9(1): 96-110
Goldstein, M.J., Mitchell, E.P. (2005) Carcinoembryonic Antigen in the Staging and Follow-up of Patients with Colorectal Cancer. Cancer Investigation, 23(4): 338-351
Gunderson, L.L., Jessup, J.M., Sargent, D.J., Greene, F.L., Stewart, A.K. (2010) Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data. Journal of Clinical Oncology, 28(2): 264-271
Hammarström, S. (1999) The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues. Seminars in Cancer Biology, 9(2): 67-81
Harrison, L., Guillem, J.G., Paty, P., i dr. (1997) Preoperative Carcinoembryonic Antigen Predicts Outcomes in Node-Negative Colon Cancer Patients: A Multivariate Analysis of 572 Patients. Journal of the American College of Surgeons, 185(1): 55-59
Li, M., Dai, C., Wang, Y., Chen, T., Wang, L., Yang, P., Xie, D., Mao, R., Chen, C. (2016) Marital status is an independent prognostic factor for tracheal cancer patients: an analysis of the SEER database. Oncotarget, 7(47)
Li, Q., Gan, L., Liang, L., Li, X., Cai, S. (2015) The influence of marital status on stage at diagnosis and survival of patients with colorectal cancer. Oncotarget, 6(9)
Lou, Z., Meng, R.G., Zhang, W., i dr. (2013) Preoperative carcinoembryonic antibody is predictive of distant metastasis in pathologically T1 colorectal cancer after radical surgery. World Journal of Gastroenterology, 19(3): 389
Lucha, P.A., Rosen, L., Olenwine, J.A., Reed, J.F., Riether, R.D., Stasik, J.J., Khubchandani, I.T. (1997) Value of carcinoembryonic antigen monitoring in curative surgery for recurrent colorectal carcinoma. Diseases of the Colon and Rectum, 40(2): 145-149
Moertel, C.G., o'Fallon Judith, R., Go, V.L. W., o'Connell Michael, J., Thynne, G.S. (1986) The preoperative carcinoembryonic antigen test in the diagnosis, staging, and prognosis of colorectal cancer. Cancer, 58(3): 603-610
Ogata, Y., Murakami, H., Sasatomi, T., Ishibashi, N., Mori, S., Ushijima, M., Akagi, Y., Shirouzu, K. (2009) Elevated preoperative serum carcinoembrionic antigen level may be an effective indicator for needing adjuvant chemotherapy after potentially curative resection of stage II colon cancer. Journal of Surgical Oncology, 99(1): 65-70
Park, I.J., Choi, G., Lim, K.H., Kang, B.M., Jun, S.H. (2009) Serum Carcinoembryonic Antigen Monitoring After Curative Resection for Colorectal Cancer: Clinical Significance of the Preoperative Level. Annals of Surgical Oncology, 16(11): 3087-3093
Park, J. W., Chang, H. J., Kim, B. C., Yeo, H. Y., Kim, D. Y. (2013) Clinical validity of tissue CEA expression as ancillary to serum CEA concentration in patients curatively resected for colorectal cancer. Colorectal Disease
Park, Y.J., Park, K.J., Park, J., Lee, K.U., Choe, K.J., Kim, J. (1999) Prognostic Factors in 2230 Korean Colorectal Cancer Patients: Analysis of Consecutively Operated Cases. World Journal of Surgery, 23(7): 721-726
Puppa, G., Sonzogni, A., Colombari, R., i dr. (2010) TNM staging system of colorectal carcinoma: a critical appraisal of challenging issues. Archives of pathology and laboratory medicine, 134(6): 837-52; doi: 10.1043/1543-2165-134.6.837
Siegel, R.L., Miller, K.D., Jemal, A. (2018) Cancer statistics, 2018. CA: A Cancer Journal for Clinicians, 68(1): 7-30
Sobin, L.H. (2003) TNM: Evolution and relation to other prognostic factors. Seminars in Surgical Oncology, 21(1): 3-7
Steele, G., Ellenberg, S., Ramming, K., Oʼconnell, M., Moertel, C., Lessner, H., Bruckner, H., Horton, J., Schein, P., Zamcheck, N., Novak, J., Holyoke, E. D. (1982) CEA Monitoring Among Patients in Multi-institutional Adjuvant G.I. Therapy Protocols. Annals of Surgery, 196(2): 162-169
Thirunavukarasu, P., Sukumar, S., Sathaiah, M., Mahan, M., Pragatheeshwar, K.D., Pingpank, J.F., Zeh, H., Bartels, C.J., Lee, K.K.W., Bartlett, D.L. (2011) C-stage in Colon Cancer: Implications of Carcinoembryonic Antigen Biomarker in Staging, Prognosis, and Management. JNCI: Journal of the National Cancer Institute, 103(8): 689-697
Thirunavukarasu, P., Talati, C., Munjal, S., Attwood, K., Edge, S.B., Francescutti, V. (2015) Effect of Incorporation of Pretreatment Serum Carcinoembryonic Antigen Levels Into AJCC Staging for Colon Cancer on 5-Year Survival. JAMA Surgery, 150(8): 747
Wanebo, H.J., Rao, B., Pinsky, C.M., Hoffman, R.G., Stearns, M., Schwartz, M.K., Oettgen, H.F. (1978) Preoperative Carcinoembryonic Antigen Level as a Prognostic Indicator in Colorectal Cancer. New England Journal of Medicine, 299(9): 448-451
Wang, J.Y., Lu, C.Y., Chu, K.S., Ma, C.J., Wu, D.C., Tsai, H.L., Yu, F.J., Hsieh, J.S. (2007) Prognostic Significance of Pre- and Postoperative Serum Carcinoembryonic Antigen Levels in Patients with Colorectal Cancer. European Surgical Research, 39(4): 245-250
Wang, W.S., Lin, J.K., Chiou, T.J., i dr. (2000) Preoperative Carcinoembryonic Antigen Level as an Independent Prognostic Factor in Colorectal Cancer: Taiwan Experience. Japanese Journal of Clinical Oncology, 30(1): 12-16
Wang, X., Cao, W., Zheng, C., Hu, W., Liu, C. (2018) Marital status and survival in patients with rectal cancer: An analysis of the Surveillance, Epidemiology and End Results (SEER) database. Cancer Epidemiology, (54): 119-124
Wang, X., Qian, J., Bai, D., Li, Z., Jiang, G., Yao, J. (2016) Marital status independently predicts pancreatic cancer survival in patients treated with surgical resection: an analysis of the SEER database. Oncotarget, 7(17)
Wu, C., Chen, P., Qian, J., Jin, S., Yao, J., Wang, X., Bai, D., Jiang, G. (2016) Effect of marital status on the survival of patients with hepatocellular carcinoma treated with surgical resection: an analysis of 13,408 patients in the surveillance, epidemiology, and end results (SEER) database. Oncotarget, 7(48)
Wu, Y., Ai, Z., Xu, G. (2017) Marital status and survival in patients with non-small cell lung cancer: an analysis of 70006 patients in the SEER database. Oncotarget, 8(61)
Yarbro, J.W., Page, DL., Fielding, L.P., i dr. (1999) American Joint Committee on Cancer prognostic factors consensus conference. Cancer, 86(11): 2436-46
Yeh, C., Hsieh, P., Chiang, J., Lai, C., Chen, J., Wang, J., Hung, H. (2011) Preoperative Carcinoembryonic Antigen (CEA) Elevation in Colorectal Cancer. Hepatogastroenterology, 58(109): 1171-1176
 

O članku

jezik rada: engleski
vrsta rada: članak
DOI: 10.2298/AOO181029007G
objavljen u SCIndeksu: 14.02.2019.
metod recenzije: jednostruko anoniman
Creative Commons License 4.0